Pegylated Liposomal Doxorubicin (Doxil®) Versus Doxorubicin...

Clinical Breast Cancer 2002 Vol. 3; Iss. 3

Pegylated Liposomal Doxorubicin (Doxil®) Versus Doxorubicin for First-Line Treatment of Metastatic Breast Cancer

Kavita Maung, Joyce O'Shaughnessy, Beth Overmoyer
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
3
Year:
2002
Language:
english
DOI:
10.1016/s1526-8209(11)70179-3
File:
PDF, 103 KB
english, 2002
Conversion to is in progress
Conversion to is failed